GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » Equity-to-Asset

Abbott India (BOM:500488) Equity-to-Asset : 0.71 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Abbott India's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹36,989 Mil. Abbott India's Total Assets for the quarter that ended in Mar. 2024 was ₹51,935 Mil. Therefore, Abbott India's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.71.

The historical rank and industry rank for Abbott India's Equity-to-Asset or its related term are showing as below:

BOM:500488' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.67   Med: 0.69   Max: 0.74
Current: 0.71

During the past 13 years, the highest Equity to Asset Ratio of Abbott India was 0.74. The lowest was 0.67. And the median was 0.69.

BOM:500488's Equity-to-Asset is ranked better than
68.91% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:500488: 0.71

Abbott India Equity-to-Asset Historical Data

The historical data trend for Abbott India's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Equity-to-Asset Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.68 0.67 0.70 0.71

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 - 0.69 - 0.71

Competitive Comparison of Abbott India's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Abbott India's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Abbott India's Equity-to-Asset falls into.



Abbott India Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Abbott India's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=36988.9/51934.9
=0.71

Abbott India's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=36988.9/51934.9
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (BOM:500488) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Abbott India Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Abbott India's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines